Not currently recruiting at UC Health
A Phase I/II Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSF
- Dates
- study startedestimated completion
- Principal Investigator
- by Miguel Pampaloni (ucsf)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UC Health
- Miguel Pampaloni (ucsf)
Miguel Hernandez Pampaloni, MD, PhD, is the Director of Nuclear Cardiology for the Molecular Imaging and Therapeutics Clinical Section in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. Dr. Pampaloni is responsible for overseeing nuclear cardiology and development of new techniques to evaluate cardiac metabolism and function.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Nordic Nanovector
- ID
- NCT01796171
- Phase
- Phase 1/2
- Study Type
- Interventional
- Last Updated